SAN DIEGO, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced commencement of the Company’s pivotal Phase 3 clinical study ...

Daré Bioscience, in collaboration with Strategic Science & Technologies, announced plans for a Phase 3 clinical study of Sildenafil Cream, 3.6%, aimed at treating female sexual arousal disorder (FSAD) ...

Webinar to be held Tuesday, July 11, 2023, at 4:30 p.m. EDT will include presentations by Daré management and key opinion leaders in sexual medicine SAN DIEGO, July 11, 2023 (GLOBE NEWSWIRE) -- Daré ...

Satellos Bioscience Inc. ((MSCLF)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert ...

Exalenz Bioscience is collaborating with the Acute Liver Failure Study Group. 1. Exalenz Bioscience and the Acute Liver Failure Study Group will study the ability of the BreathID Methacetin Breath ...

TROY, Mich.--(BUSINESS WIRE)--ZIVO Bioscience, Inc. (OTCQB: ZIVO), a pioneering biotech/agtech R&D company dedicated to developing therapeutic, medicinal and nutritional product candidates derived ...

MINNEAPOLIS--(BUSINESS WIRE)--Vergent Bioscience, a clinical-stage biotechnology company developing tumor-targeted imaging agents, announced that the company has enrolled the first patients in a Phase ...

Beetroot juice, which is rich in nitrates, has been linked to changing the community of bacteria living in the mouth. Now, a new study has found that drinking this juice could reduce older adults’ ...

A $60,000 federal grant was announced Monday to help expand the region’s existing bioscience sector. U.S. Rep. Paul Kanjorski, D-Nanticoke, and Secretary of the Pennsylvania Department of ...

ZIVO Bioscience, Inc. (OTCQB: ZIVO), a pioneering biotech/agtech R&D company dedicated to developing therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, ...